Axsome Therapeutics(AXSM) - 2024 Q4 - Earnings Call Transcript

Axsome Therapeutics (AXSM) Q4 2024 Earnings Call February 18, 2025 08:00 AM ET Company Participants Darren Opland - Director of Corporate CommunicationsHerriot Tabuteau - Founder, Chairman, CEO & PresidentNick Pizzie - CFOAri Maizel - Chief Commercial OfficerRaghuram Selvaraju - Managing Director, Healthcare Equity ResearchMark Jacobson - Chief Operating OfficerMarc Goodman - Senior MD - NeuroscienceGraig Suvannavejh - Managing DirectorHunter Murdock - General Counsel & SecretaryCerena Chen - VP - Biotech a ...